Functional status analysis of RNH1 in bladder cancer for predicting immunotherapy response

Bladder cancer (BLCA) typically has a poor prognosis due to high rates of relapse and metastasis. Although the emergence of immunotherapy brings hope for patients with BLCA, not all patients will benefit from it. Identifying some markers to predict treatment response is particularly important. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sen, Ran, Jun, Fan, Zhouqian, Liu, Mingyou, Wu, Liang, Li, Qiude, Peng, Jian, Hu, Zuquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400633/
https://www.ncbi.nlm.nih.gov/pubmed/37537337
http://dx.doi.org/10.1038/s41598-023-39827-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400633/
https://www.ncbi.nlm.nih.gov/pubmed/37537337
http://dx.doi.org/10.1038/s41598-023-39827-7

Ejemplares similares